Compare CDW Corp. (CDW) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CDW Corp. vs GSK plc — how do they compare? CDW Corp. trades at $135 (market cap $16.92B), while GSK plc trades at $50.56 (market cap $102.60B). The key difference: GSK plc is far larger — about 6.1× CDW Corp.'s market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| CDW | GSK | |
|---|---|---|
Market Cap | $16.92B | $102.60B |
Sector | Technology | Health |
52-Week High | $170.77 | $61.18 |
52-Week Low | $99.30 | $38.22 |
Enterprise Value | $22.52B | $123.04B |
Dividend Yield | 1.86% | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CDW Corp.
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
